[1]
E. Rollet, S. Puigrenier, A. Najem, B. Desgrousilliers, and P. Riviere, “Successful Immunotherapy Rechallenge Without Recurrence of Hemophagocytic Lymphohistiocytosis in a Patient With Metastatic Endometrial Cancer Previously Treated With Dostarlimab”, World J Oncol, vol. 16, no. 6, pp. 661–663, Oct. 2025, doi: 10.14740/wjon2661.